Platelet monoamine oxidase (MAO) activity and alcoholism: is there a genuine association?

C K Farren1

  • 1Department of Psychiatry, Yale University, Connecticut, USA.

Addiction Biology
|January 7, 2016
PubMed

Insights

Lower monoamine oxidase (MAO) activity was once thought to be a marker for alcoholism. However, confounding factors like smoking have weakened this association, suggesting a broader link to addiction predisposition.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Monoamine oxidase (MAO) is a key enzyme in neurotransmitter metabolism.
  • Previous research suggested lower MAO activity in individuals with alcoholism.
  • The reliability of MAO activity as an alcoholism marker is debated due to confounding factors.

Purpose of the Study:

  • To critically evaluate the association between MAO activity and alcoholism.
  • To identify and analyze potential confounding variables influencing MAO activity measurements.
  • To re-examine the hypothesis in light of new evidence and potential broader implications.

Main Methods:

  • Review and analysis of existing literature on MAO activity and alcoholism.
  • Identification of confounding factors: abstinence duration, substrate, gender, alcoholism subtypes, psychopathology, personality traits, smoking, and transmission.
  • Critical assessment of study methodologies and reported findings.

Main Results:

  • The association between low MAO activity and alcoholism is weakened by numerous confounding variables.
  • Smoking, in particular, is identified as a major confounder in many previous studies.
  • Typology-based studies have increasingly failed to support MAO activity as a specific alcoholism marker.

Conclusions:

  • The hypothesis of MAO activity as a direct marker for alcoholism requires significant re-evaluation.
  • Low MAO activity may be associated with a generalized predisposition to addiction and psychopathology.
  • Further research is needed to clarify the complex relationship between MAO activity, personality traits, and addiction.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.5K
Radical Oxidation of Allylic and Benzylic Alcohols01:21

Radical Oxidation of Allylic and Benzylic Alcohols

Activated manganese(IV) oxide can selectively oxidize allylic and benzylic alcohols via a radical intermediate mechanism. Primary allylic alcohols are oxidized to aldehydes, while secondary allylic alcohols yield ketones. The redox reaction of potassium permanganate with an Mn(II) salt such as manganese sulfate (under either alkaline or acidic conditions), followed by thorough drying, yields the oxidizing agent: activated MnO2. While MnO2 is insoluble in the solvents used for the reaction, the...
3.1K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
3.0K